Page last updated: 2024-08-22

schizandrin and Cardiomyopathy, Hypertrophic Obstructive

schizandrin has been researched along with Cardiomyopathy, Hypertrophic Obstructive in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Geng, K; Shao, W; Shen, C; Shen, P; Wang, X; Xie, H	1

Other Studies

1 other study(ies) available for schizandrin and Cardiomyopathy, Hypertrophic Obstructive

Article	Year
Integrating Bioinformatics and Network Pharmacology to Explore the Therapeutic Target and Molecular Mechanisms of Schisandrin on Hypertrophic Cardiomyopathy. Current computer-aided drug design, 2023, Volume: 19, Issue:3 Topics: Adolescent; Cardiomyopathy, Hypertrophic; Computational Biology; ErbB Receptors; Humans; Matrix Metalloproteinase 3; Molecular Docking Simulation; Network Pharmacology; Phosphatidylinositol 3-Kinases; PPAR gamma; Proto-Oncogene Proteins c-akt	2023

Article

Year

Integrating Bioinformatics and Network Pharmacology to Explore the Therapeutic Target and Molecular Mechanisms of Schisandrin on Hypertrophic Cardiomyopathy.

Current computer-aided drug design, 2023, Volume: 19, Issue:3

Topics: Adolescent; Cardiomyopathy, Hypertrophic; Computational Biology; ErbB Receptors; Humans; Matrix Metalloproteinase 3; Molecular Docking Simulation; Network Pharmacology; Phosphatidylinositol 3-Kinases; PPAR gamma; Proto-Oncogene Proteins c-akt

2023